Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3843)
All Articles published online
|
May 15, 2003 (publication date) through May 11, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lin LJ, Zheng CQ, Jin Y, Ma Y, Jiang WG, Ma T. Expression of survivin protein in human colorectal carcinogenesis. World J Gastroenterol 2003; 9(5): 974-977 [PMID: 12717841 DOI: 10.3748/wjg.v9.i5.974] |
|---|---|
| URL: | https://www.wjgnet.com/2220-3230/full/v9/i5/974.htm |
| Number | Citing Articles |
| 1 |
Zuzana Kováčová, Ingrid Hodorová. Carbonic Anhydrase IX and Survivin in Colorectal Adenocarcinoma Cells: Slovakian Population Study. Biology 2021; 10(9): 872 doi: 10.3390/biology10090872
|
| 2 |
Kristian Daly, Soraya P. Shirazi-Beechey. Microarray Analysis of Butyrate Regulated Genes in Colonic Epithelial Cells. DNA and Cell Biology 2006; 25(1): 49 doi: 10.1089/dna.2006.25.49
|
| 3 |
Mohammad Reza Sam, Parinaz Ahangar, Vahid Nejati, Reza Habibian. Treatment of LS174T colorectal cancer stem-like cells with n-3 PUFAs induces growth suppression through inhibition of survivin expression and induction of caspase-3 activation. Cellular Oncology 2016; 39(1): 69 doi: 10.1007/s13402-015-0254-4
|
| 4 |
Bela Bodey, Bela Bodey Jr, Stuart E Siegel. Mechanisms and markers of carcinogenesis and neoplastic progression. Expert Opinion on Biological Therapy 2005; 5(10): 1317 doi: 10.1517/14712598.5.10.1317
|
| 5 |
Quan-Xing Ge, Yu-Yuan Li, Yu-Qiang Nie, Wen-Ge Zuo, Yan-Lei Du. Expression of survivin and its four splice variants in colorectal cancer and its clinical significances. Medical Oncology 2013; 30(2) doi: 10.1007/s12032-013-0535-6
|
| 6 |
F. Mehrkhani, S. Nasiri, K. Donboli, A. Meysamie, A. Hedayat. Prognostic factors in survival of colorectal cancer patients after surgery. Colorectal Disease 2009; 11(2): 157 doi: 10.1111/j.1463-1318.2008.01556.x
|
| 7 |
Chao-Jie Wang, Zong-Guang Zhou, Annica Holmqvist, Hong Zhang, Yuan Li, Gunnar Adell, Xiao-Feng Sun. Survivin Expression Quantified by Image Pro-plus Compared With Visual Assessment. Applied Immunohistochemistry & Molecular Morphology 2009; 17(6): 530 doi: 10.1097/PAI.0b013e3181a13bf2
|
| 8 |
Kyung Hee Lee, Eun Young Choi, Sung Ae Koh, Min Kyoung Kim, Kyeong Ok Kim, Si Hyung Lee, Byung Ik Jang, Se Won Kim, Sang Woon Kim, Sun Kyo Song, Joon Hyuk Choi, Jae-Ryong Kim. Down-regulation of survivin suppresses uro-plasminogen activator through transcription factor JunB. Experimental and Molecular Medicine 2011; 43(9): 501 doi: 10.3858/emm.2011.43.9.057
|
| 9 |
Seok-Soo Byun, Woon Geol Yeo, Sang Eun Lee, Eunsik Lee. Expression of Survivin in Renal Cell Carcinomas: Association with Pathologic Features and Clinical Outcome. Urology 2007; 69(1): 34 doi: 10.1016/j.urology.2006.09.024
|
| 10 |
Qing-Jian Ou, Xiao-Jun Wu, Jian-Hong Peng, Rong-Xin Zhang, Zhen-Hai Lu, Wu Jiang, Lin Zhang, Zhi-Zhong Pan, De-Sen Wan, Yu-Jing Fang. Endocrine therapy inhibits proliferation and migration, promotes apoptosis and suppresses survivin protein expression in colorectal cancer cells. Molecular Medicine Reports 2017; 16(5): 5769 doi: 10.3892/mmr.2017.7375
|
| 11 |
Zaiping Liu, Hongbing Li, Mathieu Derouet, Jorge Filmus, Eric C. LaCasse, Robert G. Korneluk, Robert S. Kerbel, Kirill V. Rosen. ras Oncogene Triggers Up-regulation of cIAP2 and XIAP in Intestinal Epithelial Cells. Journal of Biological Chemistry 2005; 280(45): 37383 doi: 10.1074/jbc.M503724200
|
| 12 |
Annica Knutsen, Gunnar Adell, Xiao-Feng Sun. Survivin expression is an independent prognostic factor in rectal cancer patients with and without preoperative radiotherapy. International Journal of Radiation Oncology*Biology*Physics 2004; 60(1): 149 doi: 10.1016/j.ijrobp.2004.02.007
|
| 13 |
Xuehu Wang, Zhongxue Fu, Yu Zhao, Wei Shen, Xingye Wu, Chunyi Wang. Survivin: an overexpression protein with notable cellular localization and multiple roles in colon cancer. The Chinese-German Journal of Clinical Oncology 2010; 9(9): 519 doi: 10.1007/s10330-010-0664-8
|
| 14 |
Shuji Iida, Hirotoshi Hasegawa, Koji Okabayashi, Konosuke Moritani, Makio Mukai, Yuko Kitagawa. Risk Factors for Postoperative Recurrence in Patients with Pathologically T1 Colorectal Cancer. World Journal of Surgery 2012; 36(2): 424 doi: 10.1007/s00268-011-1378-y
|
| 15 |
Senthil K. Radhakrishnan, Andrei L. Gartel. A Novel Transcriptional Inhibitor Induces Apoptosis in Tumor Cells and Exhibits Antiangiogenic Activity. Cancer Research 2006; 66(6): 3264 doi: 10.1158/0008-5472.CAN-05-3940
|
| 16 |
Seok Young Lee, Yoon Jung Choi, Jung Gu Kang, Eun Ji Chung, Yong Tai Kim. Pathological Analysis of Tumor Response after Preoperative Chemoradiation Therapy for Advanced Rectal Cancer. Journal of the Korean Society of Coloproctology 2007; 23(6): 511 doi: 10.3393/jksc.2007.23.6.511
|
| 17 |
Laura Bongiovanni, Eliane J. Müller, Leonardo Della Salda. Survivin in skin pathologies. Experimental Dermatology 2011; 20(6): 457 doi: 10.1111/j.1600-0625.2011.01273.x
|
| 18 |
Andreas Krieg, Thomas A. Werner, Pablo E. Verde, Nikolas H. Stoecklein, Wolfram T. Knoefel, Srinivasa M. Srinivasula. Prognostic and Clinicopathological Significance of Survivin in Colorectal Cancer: A Meta-Analysis. PLoS ONE 2013; 8(6): e65338 doi: 10.1371/journal.pone.0065338
|
| 19 |
I J Goossens-Beumer, E C M Zeestraten, A Benard, T Christen, M S Reimers, R Keijzer, C F M Sier, G J Liefers, H Morreau, H Putter, A L Vahrmeijer, C J H van de Velde, P J K Kuppen. Clinical prognostic value of combined analysis of Aldh1, Survivin, and EpCAM expression in colorectal cancer. British Journal of Cancer 2014; 110(12): 2935 doi: 10.1038/bjc.2014.226
|
| 20 |
Zhonghong Liu, Yonghang Guo, Juan Li, Jun Xu, Bingrong Liu. Cotransfection of Survivin and CD44v3 Short Hairpin RNAs Affects Proliferation, Apoptosis, and Invasiveness of Colorectal Cancer. Digestive Diseases and Sciences 2013; 58(6): 1590 doi: 10.1007/s10620-012-2539-z
|
| 21 |
Ming Cai, Guo-bin Wang, Kai-xiong Tao, Chang-xue Cai. Enhanced Chemotherapy Sensitivity of Human Colon Cancer Cells to 5-Fluorouracil by siRNA Recombinant Expression Vector Targeting Survivin Gene. Chinese Medical Sciences Journal 2009; 24(2): 97 doi: 10.1016/S1001-9294(09)60069-9
|
| 22 |
J. G. Kalliakmanis, Ch. Kouvidou, C. Latoufis, G. Kouvatseas, D. Anagnostakis, G. Papatheodoridis, J. Koskinas, A. Archimandritis. Survivin Expression in Colorectal Carcinomas: Correlations with Clinicopathological Parameters and Survival. Digestive Diseases and Sciences 2010; 55(10): 2958 doi: 10.1007/s10620-009-1088-6
|
| 23 |
Marian Adamkov, Desanka Výbohová, Veronika Tupá, Jaroslava Chylíková, Jaroslav Horáček, Marián Benčat. Expression and significance of survivin in colorectal high grade and low grade adenomas. Acta Histochemica 2015; 117(6): 590 doi: 10.1016/j.acthis.2015.05.006
|
| 24 |
F Li. Role of survivin and its splice variants in tumorigenesis. British Journal of Cancer 2005; 92(2): 212 doi: 10.1038/sj.bjc.6602340
|
| 25 |
Anna Parenti, Genesio Leo, Andrea Porzionato, Giovanni Zaninotto, Antonio Rosato, Vito Ninfo. Expression of survivin, p53, and caspase 3 in Barrett's esophagus carcinogenesis. Human Pathology 2006; 37(1): 16 doi: 10.1016/j.humpath.2005.10.003
|
| 26 |
Alfred King-Yin Lam, Said Saleh, Robert Anthony Smith, Yik-Hong Ho. Quantitative analysis of survivin in colorectal adenocarcinoma: increased expression and correlation with telomerase activity. Human Pathology 2008; 39(8): 1229 doi: 10.1016/j.humpath.2008.01.001
|
| 27 |
Zhen-Ning Wang, Hui-Mian Xu, Li Jiang, Xin Zhou, Chong Lu, Xue Zhang. Expression of survivin in primary and metastatic gastric cancer cells obtained by laser capture microdissection. World Journal of Gastroenterology 2004; 10(21): 3094-3098 doi: 10.3748/wjg.v10.i21.3094
|
| 28 |
Su Liping, Wang Ying, Xiao Mingzhen, Lin Yuan, Yu Lei. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology 2010; 110(4): 484 doi: 10.1016/j.tripleo.2010.04.009
|
| 29 |
Daniel Vallböhmer, Jeffrey H. Peters, Daniel Oh, Hidekazu Kuramochi, Daisuke Shimizu, Steven R. DeMeester, Jeffrey A. Hagen, Parakrama T. Chandrasoma, Kathleen D. Danenberg, Tom R. DeMeester, Peter Danenberg. Survivin, a potential biomarker in the development of Barrett's adenocarcinoma. Surgery 2005; 138(4): 701 doi: 10.1016/j.surg.2005.06.051
|
| 30 |
Yonggan Xue, Jimei Chi, Bobin Ning, Lijun Cheng, Wenchen Wang, Qingyu Meng, Liang Huang, Mu Ke, Sen Li, Meng Su, Baoqing Jia. A nucleus-targeting fluorescence probe for rapid diagnosis of colorectal cancer. Chemical Engineering Journal 2024; 498: 155132 doi: 10.1016/j.cej.2024.155132
|
| 31 |
Liu Zhonghong, Lin Lianjie, Zheng Changqing, He Ying, Jin Yu, Lin Yan. The influence of survivin shRNA on the cell cycle and the invasion of SW480 cells of colorectal carcinoma. Journal of Experimental & Clinical Cancer Research 2008; 27(1) doi: 10.1186/1756-9966-27-20
|
| 32 |
Jong Wook Shin, Soo Hwan Lee, Eon Sub Park. Expression of Caspase 3, Survivin, and p53 Protein in Urethane Induced Mouse Lung Carcinogenesis. Tuberculosis and Respiratory Diseases 2007; 63(3): 251 doi: 10.4046/trd.2007.63.3.251
|
| 33 |
Jonathan M. Hernandez, Jeffrey M. Farma, Domenico Coppola, Ardeshir Hakam, William J. Fulp, Dung-Tsa Chen, Erin M. Siegel, Timothy J. Yeatman, David Shibata. Expression of the Antiapoptotic Protein Survivin in Colon Cancer. Clinical Colorectal Cancer 2011; 10(3): 188 doi: 10.1016/j.clcc.2011.03.014
|
| 34 |
Janine Vonlanthen, Michal J Okoniewski, Mirco Menigatti, Elisa Cattaneo, Daniela Pellegrini-Ochsner, Ritva Haider, Josef Jiricny, Teresa Staiano, Federico Buffoli, Giancarlo Marra. A comprehensive look at transcription factor gene expression changes in colorectal adenomas. BMC Cancer 2014; 14(1) doi: 10.1186/1471-2407-14-46
|
| 35 |
Tao Chen, Changsheng Deng. Inhibitory effect of siRNA targeting survivin in gastric cancer MGC-803 cells. International Immunopharmacology 2008; 8(7): 1006 doi: 10.1016/j.intimp.2008.03.004
|
| 36 |
Roxanne Megliorino, Fu-Dong Shi, Xuan-Xian Peng, Xiao Wang, Edward K.L. Chan, Eng M. Tan, Jian-Ying Zhang. Autoimmune response to anti-apoptotic protein survivin and its association with antibodies to p53 and c-myc in cancer detection. Cancer Detection and Prevention 2005; 29(3): 241 doi: 10.1016/j.cdp.2005.03.002
|
| 37 |
Ji-Young Cha, Tai-Il Cho, Tae-Yang Park, Jae-Sung So, Se-Kyoung Choi, Eon-Sub Park. Analysis of expression of survivin, caspase 3, and p53 protein in cervical neoplasia comparing with Ki-67 index. Korean Journal of Gynecologic Oncology 2008; 19(1): 17 doi: 10.3802/kjgo.2008.19.1.17
|
| 38 |
Wei-Chang Chen, Qiang Liu, Jian-Xin Fu, Su-Ya Kang. Expression of survivin and its significance in colorectal cancer. World Journal of Gastroenterology 2004; 10(19): 2886-2889 doi: 10.3748/wjg.v10.i19.2886
|
| 39 |
Wencke Reineking, Ida E. Schauerte, Johannes Junginger, Marion Hewicker-Trautwein. Sox9, Hopx, and survivin and tuft cell marker DCLK1 expression in normal canine intestine and in intestinal adenoma and adenocarcinoma. Veterinary Pathology 2022; 59(3): 415 doi: 10.1177/03009858221079666
|
| 40 |
Dermot T. McDowell, Fraser M. Smith, John V. Reynolds, Stephen G. Maher, Collette Adida, Paul Crotty, Eoin F. Gaffney, Donal Hollywood, Brian Mehigan, Richard B. Stephens, M. J. Kennedy. Increased spontaneous apoptosis, but not survivin expression, is associated with histomorphologic response to neoadjuvant chemoradiation in rectal cancer. International Journal of Colorectal Disease 2009; 24(11): 1261 doi: 10.1007/s00384-009-0755-6
|
| 41 |
Ming Cai, Guobin Wang, Kaixiong Tao, Changxue Cai. Induction of apoptosis of human colon cancer cells by siRNA recombinant expression vector targeting survivin gene. Journal of Huazhong University of Science and Technology [Medical Sciences] 2009; 29(1): 45 doi: 10.1007/s11596-009-0109-1
|
| 42 |
Ke-Jun Nan, Hai-Xia Qin, Guang Yang. Prognostic factors in 165 elderly colorectal cancer patients. World Journal of Gastroenterology 2003; 9(10): 2207-2210 doi: 10.3748/wjg.v9.i10.2207
|
| 43 |
Ulrike Gerlach, Gian Kayser, Axel Walch, Ulrich Hopt, Jürgen Schulte‐Mönting, Martin Werner, Silke Lassmann. Centrosome‐, chromosomal‐passenger‐ and cell‐cycle‐associated mRNAs are differentially regulated in the development of sporadic colorectal cancer. The Journal of Pathology 2006; 208(4): 462 doi: 10.1002/path.1914
|
| 44 |
Yi-Ting Chen, Shu-Chuan Tsao, Hung-Pei Tsai, Jaw-Yuan Wang, Chee-Yin Chai. The X-linked inhibitor of apoptosis protein is an independent prognostic marker for rectal adenocarcinoma after preoperative chemoradiotherapy. Virchows Archiv 2016; 468(5): 559 doi: 10.1007/s00428-016-1913-1
|
| 45 |
Woong Na, Se Min Jang, Young Jin Jun, Young Soo Song, Ki‐Seok Jang, Kang Hong Lee, Kyeong Geun Lee, Hong Xiu Han, Seung Sam Paik. Clinicopathologic significance of survivin expression in colorectal adenocarcinoma. Basic and Applied Pathology 2009; 2(3): 94 doi: 10.1111/j.1755-9294.2009.01049.x
|
| 46 |
Xin Zhang, Hesheng Luo. Effects of thalidomide on growth and VEGF-A expression in SW480 colon cancer cells. Oncology Letters 2017; doi: 10.3892/ol.2017.7645
|
| 47 |
HONG CAO, CHUNHUI JIN, DEFANG HUANG, CHAO LIU, DAOQI SUN, CHENG TAN, XIAOMING ZHU, YAJUN FEI. Changes in serum IGF-1 level and tumor VEGF expression in mice with colorectal cancer under hyperglycemic conditions. Molecular Medicine Reports 2013; 7(4): 1361 doi: 10.3892/mmr.2013.1339
|